Various alphabetized medical records
Industries

Life Sciences Antitrust & Competition

CRA’s life sciences litigation support services are grounded in a comprehensive understanding of pharmaceutical, biotechnology, medical device, and diagnostic markets. For more than 30 years, our experts have consulted with major life science companies, law firms, and regulatory agencies around the globe. We provide clients with the industry and analytical expertise needed to solve our clients’ most complex issues.

Engagements

  • 01
    At risk generic entry and impact of formulary status
    In a Hatch-Waxman litigation, a first-to-file generic manufacturer asked CRA to assess changes in formulary status that would result from the at-risk entry and...
    View engagement
  • 02
    Evaluation of alleged manipulation of industry drug standard setting
    In a matter involving alleged abuse of the U.S. Pharmacopeia standard setting process, CRA examined market power for product dispensed through hospital and...
    View engagement
  • 03
    Alleged foreclosure from API supply agreements
    CRA was retained by a plaintiff generic manufacturer in antitrust litigation involving an infused hospital pharmaceutical product. At issue were claims...
    View engagement

Subscribe to receive our latest Insights.

Subscribe